NVO NOVO NORDISK A S

NYSE novonordisk.com


$ 53.05 $ -0.27 (-0.51 %)    

Friday, 24-Oct-2025 19:54:42 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 52.96
$ 53.49
$ 53.00 x 21
$ 53.45 x 30
$ 52.93 - $ 53.55
$ 44.55 - $ 111.05
8,497,647
na
238.85B
$ 0.78
$ 17.04
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 options-corner-a-reliable-quant-signal-just-flashed-again-for-pharma-giant-novo-nordisk

While Novo Nordisk has been victimized by broader market pressure, NVO stock has just flashed a reliable quant signal for bulli...

 weight-loss-drugs-are-quietly-exploding-employer-health-insurance-costs-there-is-a-quiet-alarm-bell-going-off

Employer-sponsored health insurance costs rise for third year, with average family premiums at $27,000 in 2025. Drug costs and ...

 marjorie-taylor-greene-buys-6-stocks-and-bitcoin-etf-heres-her-latest-shopping-list

Congresswoman Marjorie Taylor Greene (R-Ga.) is among the most active traders in Congress. Here's a look at her latest trad...

 novo-nordisk-foundation-proposes-lars-rebien-sorensen-as-new-board-chair-of-novo-nordisk

- Reuters

 novo-chairman-to-step-down-amid-wider-plan-to-shake-up-board--bloomberg

https://www.bloomberg.com/news/articles/2025-10-21/novo-chairman-to-step-down-amid-wider-plan-to-shake-up-board?srnd=homepage-a...

 no-place-is-risk-free-until-the-world-is-polio-free-bill-gates-urges-global-action-to-close-deadly-immunity-gaps

Polio cases drop 99.9%, but funding shortfall could undo progress. Last mile hardest as virus exploits immunity gaps.

 benzinga-bulls-and-bears-stellantis-papa-johns-oklo--and-trade-tensions-shake-chip-stocks

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

 fda-approves-novo-nordisks-oral-semaglutide-for-cardiovascular-risk-reduction-in-adults-with-type-2-diabetes-who-are-at-high-risk-including-those-who-have-not-had-a-prior-cv-event

https://www.prnewswire.com/news-releases/fda-approves-novo-nordisks-oral-semaglutide-for-cardiovascular-cv-risk-reduction-in-ad...

 trumps-weight-loss-drug-push-may-put-these-etfs-on-a-diet

Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.

 trump-induced-volatility-aside-novo-trades-cheap-while-patents-protect-its-profits-until-2032

Novo Nordisk offers cheap stock with strong moat and long-term growth tailwinds. Trump's drug price cut suggestion caused s...

 novo-nordisk-stock-is-falling-friday-whats-driving-the-action

Shares of Danish pharmaceutical giant Novo Nordisk are trading lower Friday morning, continuing an after-hours slide that began...

 eli-lilly-shares-are-trading-lower-friday-whats-going-on

Eli Lilly shares are trading lower Friday, among other GLP-1 drug manufacturers, following Trump's comments that fat-loss ...

 novo-vs-lilly-vs-pfizer-who-wins-if-trump-slashes-the-price-of-weight-loss-drugs

Trump's promise to cut cost of Novo Nordisk A/S drug Ozempic from $1,300 to $150 shakes GLP-1 gold rush, with potential imp...

 eli-lilly-novo-nordisk-hims--hers-health-shares-move-lower-after-trump-calls-out-fat-loss-drugs

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-lo...

Core News & Articles

https://www.youtube.com/watch?v=xagrobF4q1k 

 hims--hers-stocks-150-surge-is-all-fundamentalsno-novo-no-problem

Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on heal...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION